Frank Takkinen
Stock Analyst at Lake Street
(1.56)
# 1,799
Out of 4,412 analysts
34
Total ratings
28.57%
Success rate
n/a
Average return
Main Sectors:
19 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLBT Cellebrite DI | Initiates: Buy | $13 | $10.85 | +19.82% | 1 | Apr 19, 2024 | |
| COCH Envoy Medical | Maintains: Buy | $3 → $6 | $4.91 | +22.20% | 2 | Apr 3, 2024 | |
| STXS Stereotaxis | Maintains: Buy | $3 → $4 | $2.30 | +73.91% | 2 | Mar 5, 2024 | |
| SILK Silk Road Medical | Initiates: Buy | $20 | $18.90 | +5.82% | 1 | Jan 3, 2024 | |
| CVRX CVRx, Inc. | Maintains: Buy | $21 → $32 | $15.28 | +109.42% | 2 | Dec 27, 2023 | |
| TELA TELA Bio | Reiterates: Buy | $14 | $4.52 | +209.73% | 1 | Dec 27, 2023 | |
| NPCE NeuroPace | Reiterates: Buy | $12 | $13.53 | -11.31% | 2 | Dec 27, 2023 | |
| ELUT Elutia | Initiates: Buy | $3 | $2.94 | +2.04% | 1 | Sep 28, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4 | $2.23 | +79.37% | 1 | Sep 7, 2023 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $22 → $15 | $5.33 | +181.43% | 2 | Aug 9, 2023 | |
| INSP Inspire Medical Systems | Maintains: Buy | $305 → $350 | $243.61 | +43.67% | 1 | Aug 2, 2023 | |
| ICAD iCAD, Inc. | Maintains: Buy | $2.5 → $5 | $1.48 | +237.84% | 3 | Jul 19, 2023 | |
| APYX Apyx Medical | Maintains: Buy | $6 → $9 | $1.40 | +542.86% | 3 | Jun 15, 2023 | |
| BIOL BIOLASE | Maintains: Buy | $150 → $40 | $0.15 | +26,302.64% | 2 | May 31, 2023 | |
| EDAP EDAP TMS | Maintains: Buy | $14 → $16 | $7.26 | +120.39% | 2 | May 18, 2023 | |
| PAVM PAVmed | Maintains: Buy | $31 → $9.23 | $1.71 | +439.77% | 2 | Jan 18, 2023 | |
| NOTV Inotiv | Upgrades: Buy | $4 → $10 | $3.74 | +167.38% | 4 | Jan 11, 2023 | |
| AORT Artivion | Initiates: Buy | $32 | $20.60 | +55.34% | 1 | Aug 8, 2022 | |
| BTCY Biotricity | Initiates: Buy | $30 | $1.31 | +2,190.08% | 1 | Mar 7, 2022 |
Cellebrite DI
Apr 19, 2024
Initiates: Buy
Price Target: $13
Current: $10.85
Upside: +19.82%
Envoy Medical
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $4.91
Upside: +22.20%
Stereotaxis
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.30
Upside: +73.91%
Silk Road Medical
Jan 3, 2024
Initiates: Buy
Price Target: $20
Current: $18.90
Upside: +5.82%
CVRx, Inc.
Dec 27, 2023
Maintains: Buy
Price Target: $21 → $32
Current: $15.28
Upside: +109.42%
TELA Bio
Dec 27, 2023
Reiterates: Buy
Price Target: $14
Current: $4.52
Upside: +209.73%
NeuroPace
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $13.53
Upside: -11.31%
Elutia
Sep 28, 2023
Initiates: Buy
Price Target: $3
Current: $2.94
Upside: +2.04%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4
Current: $2.23
Upside: +79.37%
ClearPoint Neuro
Aug 9, 2023
Maintains: Buy
Price Target: $22 → $15
Current: $5.33
Upside: +181.43%
Inspire Medical Systems
Aug 2, 2023
Maintains: Buy
Price Target: $305 → $350
Current: $243.61
Upside: +43.67%
iCAD, Inc.
Jul 19, 2023
Maintains: Buy
Price Target: $2.5 → $5
Current: $1.48
Upside: +237.84%
Apyx Medical
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $1.40
Upside: +542.86%
BIOLASE
May 31, 2023
Maintains: Buy
Price Target: $150 → $40
Current: $0.15
Upside: +26,302.64%
EDAP TMS
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $7.26
Upside: +120.39%
PAVmed
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $1.71
Upside: +439.77%
Inotiv
Jan 11, 2023
Upgrades: Buy
Price Target: $4 → $10
Current: $3.74
Upside: +167.38%
Artivion
Aug 8, 2022
Initiates: Buy
Price Target: $32
Current: $20.60
Upside: +55.34%
Biotricity
Mar 7, 2022
Initiates: Buy
Price Target: $30
Current: $1.31
Upside: +2,190.08%